Vania Tietsche de Moraes Hungria

27PUBLICATIONS
123CO-AUTHORS
Haematological tumoursNuclear physicsNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 25, 2026
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

|Jun 03, 2026
Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

|May 12, 2026
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis.

|Jan 27, 2026
Emerging Real-World Treatment Patterns and Clinical Outcomes of Multiple Myeloma in Argentina and Brazil: Insights from the TOTEMM Study in the Private Healthcare Sector.

Vania Hungria, Angelo Maiolino, Roberto Jose Pessoa de Magalhães

|Dec 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?

Shaji Kumar, Joshua Richter, Saad Z Usmani

Pageof 5

Frequent Collaborators

7 joint publications

María-Victoria Mateos

7 joint publications

Angelo Maiolino

5 joint publications

Edvan Q Crusoé

5 joint publications

Meral Beksac